Selected article for: "high throughput and vaccine development"

Author: Oh, Soo-Jin; Choi, Young-Ki; Shin, Ok Sarah
Title: Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases
  • Document date: 2018_3_1
  • ID: ta5y54lu_3
    Snippet: Thus far, vaccines have been prepared by traditional methods, involving isolating infectious agents, attenuating or inactivating them, and exposing them to the immune system. 6 Although this traditional approach has proven very efficient ag-ainst pathogens with relatively low antigen variability, such as smallpox, polio, measles, mumps, and rubella, these approaches are not optimal to provide adequate protection against recently appearing EIDs, s.....
    Document: Thus far, vaccines have been prepared by traditional methods, involving isolating infectious agents, attenuating or inactivating them, and exposing them to the immune system. 6 Although this traditional approach has proven very efficient ag-ainst pathogens with relatively low antigen variability, such as smallpox, polio, measles, mumps, and rubella, these approaches are not optimal to provide adequate protection against recently appearing EIDs, such as avian influenza virus infection, Ebola hemorrhagic fever, and dengue fever. 7, 8 Thus, novel systemic approaches are required to predict protective immune responses from high throughput sequencing and bioinformatics analysis and to identify potential antigenic targets to guide and accelerate vaccine development.

    Search related documents:
    Co phrase search for related documents
    • adequate protection and immune system: 1
    • adequate protection and infectious agent: 1
    • adequate protection and influenza virus: 1, 2
    • adequate protection and vaccine development: 1, 2, 3, 4
    • antigen variability and immune response: 1, 2
    • antigen variability and immune system: 1, 2
    • antigen variability and influenza virus: 1, 2, 3
    • antigen variability and influenza virus infection: 1
    • antigenic target and immune response: 1, 2, 3, 4, 5, 6, 7
    • antigenic target and immune system: 1, 2, 3, 4
    • antigenic target and influenza virus: 1, 2, 3
    • antigenic target and potential antigenic target: 1, 2, 3
    • antigenic target and vaccine development: 1, 2, 3, 4, 5, 6, 7
    • bioinformatic high throughput sequencing analysis and high throughput sequencing: 1, 2
    • bioinformatic high throughput sequencing and high throughput sequencing: 1, 2, 3, 4
    • bioinformatic high throughput sequencing and throughput sequencing: 1, 2, 3, 4